NCT00014365View on ClinicalTrials.gov

Ro 31-7453 in Treating Patients With Metastatic Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2000

Primary Completion Date

October 31, 2001

Study Completion Date

October 31, 2001

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

MKC-1

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00014365 - Ro 31-7453 in Treating Patients With Metastatic Solid Tumors | Biotech Hunter | Biotech Hunter